AI MARKET SCANNING

$ANAB

AnaptysBio, Inc.

United StatesUNITED STATES
FREE PREVIEW
AVG HISTORICAL GAP5.22%
MAX GAP RECORD18.60%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $ANAB

EXECUTIONS2 LOGS
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
2026-09-01QUANT ALGOSELL x5$•••.•• → $•••.••1228m🔒 ENCRYPTED-16.64%
••••-••-••🔒 LOCKED••• x•$•••.•• → $•••.••••h ••m🔒 LOCKED+••.••%
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY7.1%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company's products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis; ANB033, a CD122 antagonist, which is in a Phase 1b trial for celiac disease and eosinophilic… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL